Molecular Imaging and Breast Cancer - Open Event

An Open Event Presented by SNMMI at the San Antonio Breast Cancer Symposium

Dinner Symposium
Molecular Imaging and Breast Cancer: Selecting and Evaluating Targeted Treatments

Date: December 10
Time: 7:00 - 8:30 pm CST
Location: Marriott Rivercenter, San Antonio, TX
Fee: Complimentary 

SNMMI has applied for CE Credit for this live event.


6:45 pm Registration opens
7:00 pm Dinner is served

7:15 - 7:35 pm
Using FDG PET/CT to Choose Treatment and Evaluate Response
Jennifer Specht, MD

  •  Review the application of FDG PET/CT to breast cancer staging and response assessment
  • Highlight applications to challenging clinical needs, such as bone metastasis response
  • Review data on early response assessment for chemotherapy, endocrine therapy, and targeted treatments such as HER-2 targeted therapy

7:35 - 7:55 pm
Targeting Steroid Receptors: ER Imaging and Beyond
Hannah Linden, MD

  • Review the data supporting the recent approval of [18F] fluoroestradiol (FES) and approved clinical indications
  • Highlight early research data on other applications such as staging, dosing of ER blocking agents, and dual-targeted therapy
  • Review early data on other steroid receptor targets, especially progesterone receptors

7:55 - 8:15 pm
New Targets, New Tracers: HER2, PARP, and Others
Farrokh Dehdashti, MD

  • Describe the clinical targets (HER2, PARP, PgR, etc.) and radiopharmaceutical approaches to image those targets
  • Review data from early clinical studies of these new agents
  • Discuss possible applications to clinical research and clinical practice

8:15 - 8:30 pm
Panel Discussion/Q&A
David Mankoff, MD (moderator)


Farrokh Dehdashti, MD
Washington University in St. Louis
St. Louis, MO

Hannah Linden, MD
Medical Oncologist
University of Washington, Seattle Cancer Care Alliance
Seattle, WA

David MankoffDavid Mankoff, MD
Vice Chair for Research, Radiology
University of Pennsylvania
Philadelphia, PA

Jennifer Specht, MD
Medical Oncologist
University of Washington, Seattle Cancer Care Alliance
Seattle, WA

Please note: SNMMI is committed to ensuring that appropriate and necessary health and safety protocols will be in place for this event. We will follow all Centers for Disease Control and Prevention (CDC) safety protocols and recommendations and will comply with all federal, state and local regulations. Attendees must be fully vaccinated for COVID-19 and masks will be required.

CE Credit applications for physicians, pharmacists, physicists and technologists are pending. Check back for updates regarding CE Credit status

This event is presented by the Society of Nuclear Medicine and Molecular Imaging with support in the form of a medical education grant from GE Healthcare.